key: cord-0976378-6zfrt9is
authors: El-Sayed, Amr; Abdel-Daim, Mohamed M.; Kamel, Mohamed
title: Zoonotic and anthropozoonotic potential of COVID-19 and its implications for public health
date: 2021-09-14
journal: Environ Sci Pollut Res Int
DOI: 10.1007/s11356-021-16415-8
sha: 51bfd42906aceb6e2d4562660a16f10778f8a0fd
doc_id: 976378
cord_uid: 6zfrt9is

nan

Coronaviruses belonging to the Coronaviridae family are enveloped, single-stranded, positive-sense RNA viruses. Several members of coronaviruses can infect man and animals to induce respiratory and enteric diseases. To date, seven coronaviruses (-CoV) are known to be human pathogens, namely HCoV-NL63, HCoV-229E, HCoV-OC43, HKU1, SARS-CoV, MERS-CoV, and SARS-CoV-2 (Contini et al. 2020) . While SARS-CoV, MERS-CoV, and SARS-CoV-2 (betacoronaviruses) are responsible for serious and even fatal respiratory diseases, the remaining four viruses (HCoV-NL63 and HCoV-229E (alpha CoVs), and both HCoV-OC43 and HKU1 (beta CoVs)) are linked to 10-30% of the common cold and mild respiratory infections which can be accidentally fatal. Five out of these seven viruses (with the exception of HCoV-OC43 and HCoV-HKU1) seem more likely to have speciated from ancestor bat-associated viruses (El-Sayed and Kamel 2021) . Both HCoV-OC43 and HCoV-HKU1 are likely to have direct ancestral links with rodents representing as their primordial hosts. Their human transmissions may occur via domestic animals such as pigs or cattle (Corman et al. 2018 , Lau et al. 2015 . Whether the viral spillover required an intermediate host or was transmitted directly from bats to humans is not always known (Table 1) , Singla et al. 2020 , El-Sayed and Kamel 2021 . Over the past 20 years, in 2002, 2012, and 2019, serious new coronaviruses emerged for the first time, namely, SARS-CoV, MERS-CoV, and SARS-CoV-2. All of the three viruses had a zoonotic potential and represented a great public health threat (Tables 2, 3, and 4 and Figure 1 ) (Sharun et al. 2021, El-Sayed and Kamel 2021) .

Since the emergence of SARS-CoV-2 in Wuhan, the virus carried out continuous mutation and progressive evolution. Among the main initiators for continuous mutations is the ability of SARS-CoV-2 to easily cross the interspecies barrier. Such mutations aim to adapt the viral genome to its new host species. For instance, in 2002, SARS-CoV required only two mutations (K479N and S487T) to spill over from palm civet to humans. Understanding the adaptation process can help in the control of possible epizootics (Garry 2021) .

Moreover, in a recent work, mapping of 2034 different SARS-CoV-2 mutations could detect five antibody neutralization escape mutations of the virus (Starr et al. 2021) . Out of these, three mutations raised extra worry: the UK (VOC 202012/01 (B.1.1.7 lineage)), the South African (VOC 202012/02 (B.1351 lineage)), and the Brazilian Amazon (VOC 202101/02 (P.1)) variants (Burki 2021) . This concern is based on the alarming data about higher fatalities among patients infected with the B.1.1.7 lineage when compared with other patients. In addition, this mutation is characterized by its higher spread rate and ability to escape from vaccinal protection (Iacobucci 2021 , Muik et al. 2021 , Supasa et al. 2021 . SARS-CoV-2 continuous mutation represents a serious challenge for the international public health and the intensive efforts to control the pandemic through mass vaccination. The present work focuses on the zoonotic and reverse zoonotic aspects of SARS-CoV-2 and the most serious mutations of the virus.

The ongoing potential for zoonotic and anthroponotic SARS-CoV-2 transmission was highlighted following reports of viral spillover from animal to man transmission (mink to human) (Salajegheh Tazerji et al. 2020 , Jo et al. 2020 , Singla et al. 2020 , Oude Munnink et al. 2020 , and reverse spillover from human to animal transmission (man to dog and man to cat) (Salajegheh Tazerji et al. 2020 , Mallapaty 2020 , CDC 2020a , OIE 2020c . Since then, several studies were carried out to investigate the ability of SARS-CoV-2 to infect different animal species (Tables 2 and 4). SARS-CoV-2 is believed to originate from horseshoe bats. However, the intermediate host of SARS-CoV-2 remains unknown (Swelum et al. 2020, El-Sayed and Kamel 2021) . For the detection of the intermediate host of SARS-CoV-2, the serological approach was used by Zhang and his team (2020) who investigated sera from 35 different animal species (Zhang et al. 2020c) . In parallel, the molecular approach for the determination of possible intermediate hosts was carried out by Dames and his team. To achieve this goal, the team determined first the susceptible (potential target) animal species which own the required receptors for SARS-CoV-2 binding. The team studied the angiotensin-converting enzyme 2 (ACE2) sequences of 410 vertebrate species, including 252 Glycan-based receptors carrying 9-O-acetylated sialic acid and major histocompatibility complex class I (HLA class I) (Gagneur et al. 2002 , Corman et al. 2018 , Lim et al. 2016 , Collins 1994 HCoV-HKU1 β-CoV / Embecovirus Snakes (were excluded later from the list of possible intermediate hosts) (Ji et al. 2020 , Gautam et al. 2020 mammals for their binding affinity to SARS-CoV-2 (Damas et al. 2020 ). This step was followed by focussing on animal species that might play a role as intermediate hosts for SARS-CoV-2 according to the ACE2 analysis profiles (Damas et al. 2020 ) ( Table 2 ). The study of Dames and his team (2020) and similar designed studies provided valuable data not only about possible intermediate hosts but also about animal species that might maintain the virus in circulation by acting as reservoir hosts. Out of the 103 investigated species, receptor analysis referred to the possible role of 21 species of primates, including Angola colobus and rhesus macaques, in addition to various species of cervid deer and cetacean species as SARS-CoV-2 potential reservoir. Two-thirds of the involved artiodactyl mammals (e.g., domesticated large and small ruminants, wild ruminants, as well as giraffe, gazelle, okapi, hippopotamus, and scimitar-horned oryx) showed a medium score for ACE2-SARS-CoV-2 binding. Rodents varied in their susceptibility according to their species. Meanwhile, camels are unlikely to play a role in disease spread, although they are susceptible to other coronaviruses (Damas et al. 2020) .

Among the susceptible farm animal species, the small and large ruminants could be infected with SARS-CoV-2 (Praharaj et al. 2020 , water buffaloes (Praharaj et al. 2020) , rabbits (Santini and Edwards 2020, Praharaj et al. 2020) , horses (Santini and Edwards 2020, Praharaj et al. 2020) , and pigeons . Meanwhile, the poultry and farmed birds (except pigeons) are resistant to infection (Suarez et al. 2020 ). On the other hand, the role of pigs in the spread of SARS-CoV-2 is debated. While some reports confirm their epidemiological role , other reports list pigs among the animals of no epidemiological importance for COVID-19 transmission (Schlottau et al. 2020) . The severity of clinical signs in Non-susceptible animal species including guinea pig, mouse, pigs, European hedgehog, lesser hedgehog tenrec, chicken, and ducks were found referent to vulnerability (Ruiz-Arrondo et al. 2020) Schlottau et al. 2020 ) , Suarez et al. 2020 animals varies in relation to the species susceptibility to the virus being almost asymptomatic in dogs, associated with moderate respiratory and/or gastrointestinal disorders in cats, and severe and almost fatal in minks (Hobbs and Reid 2020) .

Although the high susceptibility of mink to SARS-CoV-2 infection is known since summer 2020, the decision of culling all farmed minks in Denmark was taken in the 5th of November after it was clear that the virus can spill back from mink to humans, and that the virus can mutate in the infected minks. The new mutations arose widespread public health concern as they occurred in the viral spike (S) glycoprotein, responsible for receptor binding. Such mutations may develop different invasion strategies to human cells and may not respond to already developed vaccines and therapies which may have catastrophic consequences on the international public health (Koopmans 2021 . A third reason explaining the panic and public health concern in relation to mink infections is the high evolutionary rate of the virus in mink population when compared to its evolutionary rate in human or other animal species. The high density of animals in the cages allows not only the rapid uncontrolled spread of the virus in the population but also the subjection of human workers to higher viral load due to the high mink density in farms, which can potentially shorten the generation interval for SARS-CoV-2 in humans (normally ranges around 4 to 5 days) (Oude Munnink et al. 2021) .

The international concern was calmed down through the culling of the entire farmed mink population (15 million farmed minks) in Denmark, Spain, and the Netherlands. Later on, SARS-CoV-2 could be isolated from wild freeranging American mink (Neovison vison) in Utah, USA (OIE 2021). In addition to wild free-ranging minks, the virus could also hit several mink farms in Utah, leading to severe economic losses. Mink to human viral transmission was reported where there were several staffers on Utah farms who attracted the infection after coming in contact with infected animals (Stout et al. 2021 , Shriner et al. 2021 , Cahan 2020 . In addition to the USA, mink to human viral transmission could be confirmed in the Netherlands, Spain, Italy, Sweden, and Greece (Koopmans 2021) .

The high susceptibility of minks to SARS-CoV-2 associated with virus exposure in high density populations in the farms favor sustained and rapid virus transmission. In the USA, not only mink with respiratory signs tested positively to SARS-CoV-2 but also other apparently healthy animals in the farm. The virus could spread from infected mink to infect healthy mink, and even dogs and cats in the farm (CDC 2020b). Phylogenetic analysis of SARS-CoV-2 isolates Figure 1 Zoonotic potential of SARS-CoV, MERS-CoV, and SARS-CoV-2 viruses detected in mink farms in the Netherlands revealed the presence of at least five different SARS-CoV-2 clusters (A, B, C, D, and E) which clustered with human isolates. Epidemiological data analysis indicated the zoonotic transmission of the virus from the farmed mink to the farm workers; however, the source of new human infections among the workers was not only limited to infected minks (Oude Munnink et al. 2020 , Oude Munnink et al. 2021 . In spite of their clustering in different clusters, and although several mutations were detected upon blasting the sequence of Wuhan strain with the Danish mink isolates, no amino acid substitutions occurred in all investigated mink samples. However, the high sequence diversity of mink isolates indicates the infection's persistence for several generations and its circulation in the mink population for a long time before being discovered (Oude Munnink et al. 2021) .

The evolved minks' SARS-CoV-2 mutations in Denmark and the Netherlands circulated faster in mink and human population than the original wild strains. A mink-associated S protein mutation (Y453F mutation) was detected in all mink isolates from Denmark and several farms in the Netherlands. In this mutation, tyrosine substitution with phenylalanine at amino acid 453 occurs in the RBD region (receptor binding domain). The substitution in position 453 in viral S protein contacts the ACE2 receptors at position 34, which differs between human (Histidine) and mink (Tyrosine), which indicates the adaptation of the virus to mink cellular receptors (Larsen et al. 2021 .

However, the lack of the Y453F in mink isolates indicates its minor role in the disease pathogenesis in minks. The Y453F mutation was also isolated from human patients in Russia, the USA, and South Africa without known history of mink contact. Meanwhile, the S protein (S1 subunit) of about half of the mink isolates from Denmark poses an additional deletion of histidine and valine amino acids (positions 69 and 70). The same mutation was also reported in human patients in the UK, France, Germany, Norway, Sweden, Malaysia, New Zealand, Australia, Canada, and Côte d'Ivoire (Oude Munnink et al. 2021 , Welkers et al. 2021 .

Although the cluster-five SARS-CoV-2 mutation Y453F did not provide an additional advantage to the virus such as reduction of antibody neutralization capacity or escape from vaccinal protection, it enhanced the viral transmission process the providing fourfold higher ACE2 receptor binding affinity in comparison to the wild-type RBD-spike binding potential (Rafael Bayarri-Olmos et al. 2021) .

In mink isolates, additional mutations were also reported in S protein sequence, including the I692V and M1229I mutations (Oude Munnink et al. 2021 , Welkers et al. 2021 or L452M, F486L, and N501T mutations which were observed in the receptor binding motif (RBM) of mink SARS-CoV-2 isolates (Elaswad et al. 2020) . Notably, the N501T mutation improved the efficiency of SARS-CoV-2 binding to mink and ferret ACE2 receptors which indicate viral adaptation to the mustelid members. Similarly, infection of felines or canines with SARS-CoV-2 resulted in new mutations to adapt to its new host species (Garry 2021) .

Different combinations of the previously listed mutations can occur which result in the presence of the different variants such as (453F), (69-70delHV, 453F), (69-70delHV, 453F, 1147L), and (69-70delHV, 453F, 692V, 1229I) isolates .

However, the transmissibility potential of mink-related SARS-CoV-2 mutations remained as the original isolates. Even humans infected with cluster 5 did not show additional clinical signs. The prevalence of detection of mink related isolates in the population potentially dropped following culling of farmed minks (ECDC 2020).

Among the reported SARS-CoV-2 mutations are the D614G isolates characterized by the presence of a point mutation in the viral S protein which led to the substitution of an aspartic acid-to-glycine at amino acid position 614. Mutated isolates were not reported in original Wuhan isolates as they were first identified in late January 2020, and began emerging in March (Zhang et al. 2020b , Daniloski et al. 2021 ). At that time (March 2020), analysis of SARS-CoV-2 genomes revealed the emergence of four new genetic clusters characterized by being super-spreaders (SSs) (Yang et al. 2020a ). The mutated isolates significantly shorter infection doubling time from more than 6 days in original Wuhan isolates to 3 days (Jackson et al. 2021) .

This mutation provided a clear phenotypic advantage as it enabled better binding to human ACE2 receptors. The better binding affinity is not only reflected on the speed of spread (up to 8-fold more effective spread than wild-type S-Virus) but also enhanced the infectivity of the virus (3-fold higher viral load in the patients). Therefore, they could rapidly surpass other isolates in prevalence so that most of the circulating strains at present and supplanted S(D614) globally as the predominant form of the virus (Jackson et al. 2021) .

The enhancement of the viral binding and ability to enter the cells through the substitution of aspartic acidto-glycine amino acid is not fully understood. However, several hypotheses were suggested such as this substitution: (1) improves the cleavage efficiency of spike protein, (2) reform the shape of the S protein to favour better RBD-ACE2 interaction, (3) increase the density of the S proteins on the outer surface of the virus, (4) increases the stability of spike trimers, or possibly (5) the mutated viruses are more resistant to be neutralized by the antibodies (Jackson et al. 2021 ).

The zoonotic and reverse zoonotic SARS-CoV-2 transmission was reported between human and (1) domestic cats (man to cat) (Hosie et al. 2021 ) and cat to man (Zhang et al. 2020d , Patterson et al. 2020 ); (2) man to mink (Oreshkova et al. 2020 , Oude Munnink et al. 2020 ) and mink to man (Oude Munnink et al. 2020 ); man to ferrets, mice, hamsters, and captive gorillas (Hedman et al. 2021) . To the present time, the dogs, lions, and tigers are considered to be dead-end of the infection where man to dog (Sit et al. 2020 , Patterson et al. 2020 ), lion (McAloose et al. 2020 ), and tiger (McAloose et al. 2020 transmission could be reported but not the reverse one ( Figure 2 ).

One Health approach to control the disease SARS-CoV-2 is a serious problem for the international community at present. The virus can invade various body systems and lead to organ dysfunction (El-Sayed et al. 2021a , El-Sayed et al. 2021b . The wide host range of SARS-CoV-2 and its geographical distributions raised the alarms of a panzootic accompanying the actual pandemic situation (Enserink 2020 , Manes et al. 2020 , WHO report 2020 , James Gorman 2020 . For the pandemic control, several COVID-19 vaccines are now commercially available to prevent further spread of the disease among humans (CDC 2019, Creech et al. 2021) (Table 5) . However, despite the present restricted biosecurity measures and early warning surveillance, immunization of human population alone is not enough as the virus started to endemize in all susceptible species to prevent viral spillover back to humans. It is well confirmed that SARS-CoV-2 can infect several domestic and wild animal species and circulate in wild animals. It cannot be excluded that the virus will continue to mutate. Further evolution towards higher fatality or potential to spread, or the occurrence of new mutations is the ongoing present threat. The change in viral antigenicity may lead to failure of coverage by the already available vaccines, increase risk of re-infection, and failure of therapeutic benefits by the administration of monoclonal antibodies or convalescent patients' plasma, which would have catastrophic effects on global public health and economy. Therefore, it is important to apply a robust (One Health approach/Human-Animal-ecosystem) concept to combat the ongoing pandemic and future similar emerging zoonotic disease events (Sharun et al. 2021, Hobbs and Reid 2020) . One of the urgent responses among the required measures is developing vaccines for veterinary uses in parallel to those adopted for human use. Pioneer trials to develop COVID-19 animal vaccines were carried out by Zoetis which developed a SARS-CoV-2 vaccine for domestic and zoo animals. The vaccine was primarily designed for and test in pet animals and could provide high protection and safety levels. Following the emergency culling of millions of farmed minks, the vaccine was shifted and adapted to minks (Zoetis 2021) . However, in the San Diego Zoo, where at least three gorillas at the Safari Park were naturally infected with the disease, the remaining great apes were subjected to infection risk. Therefore, other non-human primates, including orangutans (n=4) and bonobos (n=5), were emergency vaccinated with Zoetis experimental vaccine (Petersen 2021 , Jennewein 2021 .

In conclusion, the clear interaction between humans and animal hosts susceptible to SARS-CoV-2 and their capability to host new mutations of the virus underlines the importance of developing One Health response strategy for emerging zoonotic disease events and the parallel implementation of disease control strategies in man and animals. The developed vaccines or antiviral preparations used for the control of COVID-19 should be adapted for human and domestic animals susceptible to SARS-CoV-2 to overcome the serious public health threat.

Author contribution AE and MK manuscript writing and revision. MMA conducted manuscript moderation and revision. All the authors had contributed, critically reviewed, revised, and approved the final manuscript.

Data availability Not applicable.

Ethical approval Not applicable.

Consent for publication Not applicable.

The authors declare no competing interests. Table 5 The commercially available vaccine for humans and protection against COVID-19. Source: CDC (2019), Creech et al. (2021) 

Evidence for SARS-CoV-2 infection of animal hosts

APHIS (2020) APHIS. USDA statement on the confirmation of COVID-19 in a tiger in New York. Available online

The Middle East respiratory syndrome (MERS)

The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice

Understanding variants of SARS-CoV-2

COVID-19 hits U.S. mink farms after ripping through Europe

CDC (2020a) Confirmation of COVID-19 in two pet cats in New York. Available online

Identification of major histocompatibility complex class i c molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection

Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility

SARS-associated coronavirus transmitted from human to pig

Human coronavirus OC43 interacts with major histocompatibility complex class i molecules at the cell surface to establish infection

COVID-19 is a multifaceted challenging pandemic which needs urgent public health interventions

Hosts and sources of endemic human coronaviruses

SARS-CoV-2 vaccines

Broad host range of SARS-CoV-2 predicted by comparative and structural analysis of ACE2 in vertebrates

The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types

Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals

ECDC (2020) Detection of new SARS-CoV-2 variants related to mink -12

Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection

Mutational spectra of SARS-CoV-2 isolated from animals

Causes of respiratory failure in COVID-19 patients

COVID-19: a new emerging respiratory disease from the neurological perspective

Coronaviruses in humans and animals: the role of bats in viral evolution

Coronavirus rips through Dutch mink farms, triggering culls

Susceptibility of raccoon dogs for experimental SARS-CoV-2 infection

Mass culling of minks to protect the COVID-19 vaccines: is it rational? New Microbes New Infect 38: 100816

COVID-19: time to exonerate the pangolin from the transmission of SARS-CoV-2 to humans

Coronavirus-related nosocomial viral respiratory infections in a neonatal and paediatric intensive care unit: a prospective study

Mutations arising in SARS-CoV-2 spike on sustained human-to-human transmission and human-to-animal passage

Susceptibility to SARS, MERS, and COVID-19 from animal health perspective

SARS-CoV-2 transmission between mink (Neovison vison) and Humans

Host diversity and potential transmission pathways of SARS-CoV-2 at the human-animal interface

Animals and SARS-CoV-2: species susceptibility and viral transmission in experimental and natural conditions, and the potential implications for community transmission

Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry

Anthropogenic infection of cats during the 2020 COVID-19 pandemic

Covid-19: New UK variant may be linked to increased death rate, early data indicate

Functional importance of the D614G mutation in the SARS-CoV-2 spike protein

Orangutans and bonobos at zoo get experimental animal COVID vaccine

Cross-species transmission of the newly identified coronavirus 2019-nCoV

Potential zoonotic sources of SARS-CoV-2 infections

Infection and rapid transmission of SARS-CoV-2 in ferrets

SARS-CoV-2 and the human-animal interface: outbreaks on mink farms

SARS-CoV-2 (COVID-19): zoonotic origin and susceptibility of domestic and wild animals

Identifying SARS-CoV-2-related coronaviruses in Malayan Environ Sci Pollut Res pangolins

Preliminary report of an outbreak of SARS-CoV-2 in mink and mink farmers associated with community spread

Working paper on SARS-CoV-2 spike mutations arising in Danish mink, their spread to humans and neutralization data

Discovery of a novel coronavirus, China Rattus coronavirus HKU24, from Norway rats supports the murine origin of betacoronavirus 1 and has implications for the ancestor of Betacoronavirus lineage A

Human coronaviruses: a review of virus-host interactions

Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2

Comparison of SARS-CoV-2 infections among 3 species of nonhuman primates

SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae

Coronavirus can infect cats -dogs, not so much

Could Mustelids spur COVID-19 into a panzootic? Veterinaria italiana

From people to Panthera: natural SARS-CoV-2 infection in tigers and lions at the Bronx Zoo

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera

de Wit E (2020) Respiratory disease and virus shedding in rhesus macaques inoculated with SARS-CoV-2

OIE (2020a) A case of a Belgian cat positive for Covid-19. Available online

OIE (2020c) COVID-19 (SARS-COV-2), Hong Kong (SAR -PRC) 2020. Available online

Events in animals: OIE -World Organisation for Animal Health

SARS-CoV-2 infection in farmed minks, the Netherlands

Koopmans MP (2020) Jumping back and forth: anthropozoonotic and zoonotic transmission of SARS-CoV-2 on mink farms

Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans

Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy

In what's believed to be a first among great apes, several gorillas at San Diego Zoo in the US have been infected with COVID-19

Prediction analysis of SARS-COV-2 entry in Livestock and Wild animals

Mikkel-Ole Skjoedt (2021) The SARS-CoV-2 Y453F mink variant displays a striking increase in ACE-2 affinity but does not challenge antibody neutralization

Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: a case of an asymptomatic cat with SARS-CoV-2 in Europe

Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to animals: an updated review

Host range of SARS-CoV-2 and implications for public health

SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study

SARS-CoV-2 infection in farmed minks, associated zoonotic concerns, and importance of the One Health approach during the ongoing COVID-19 pandemic

Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2

SARS-CoV-2 exposure in escaped mink

Pathogenesis and transmission of SARS-CoV-2 in golden hamsters

Human animal interface of SARS-CoV-2 (COVID-19) transmission: a critical appraisal of scientific evidence

Infection of dogs with SARS-CoV-2

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19

Lack of susceptibility of poultry to SARS-CoV-2 and MERS-CoV

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Abd El-Hack ME (2020) COVID-19 in human, animal, and environment: a review

On the origin and continuing evolution of SARS-CoV-2

USDA (2020) Confirmed cases of SARS-CoV-2 in animals in the United States

Livestock susceptibility to infection with Middle East respiratory syndrome coronavirus

Surveillance on severe acute respiratory syndrome associated coronavirus in animals at a live animal market of Guangzhou in 2004

Possible host-adaptation of SARS-CoV-2 due to improved ACE2 receptor binding in mink

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

Evidence of recombination in coronaviruses implicating pangolin origins of nCoV-2019

Civets are equally susceptible to experimental infection by two different severe acute respiratory syndrome coronavirus isolates

Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2

Genetic cluster analysis of SARS-CoV-2 and the identification of those responsible for the major outbreaks in various countries

Swine enteric alphacoronavirus (swine acute diarrhea syndrome coronavirus): an update three years after its discovery

Protein structure and sequence reanalysis of 2019-nCoV genome refutes snakes as its intermediate host and the unique similarity between its spike protein insertions and HIV-1

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Serological survey of SARS-CoV-2 for experimental, domestic, companion and wild animals excludes intermediate hosts of 35 different species of animals

A serological survey of SARS-CoV-2 in cat in Wuhan

Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak

Susceptibility of tree shrew to SARS-CoV-2 infection

China Novel Coronavirus Investigating and Research Team (2020) A novel coronavirus from patients with pneumonia in China

COVID-19 animal vaccines | Zoetis

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations